You have 9 free searches left this month | for more free features.

Oligometastatic Sarcomas

Showing 1 - 25 of 489

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sarcoma, Radiosurgery Trial in France (Atezolizumab, SBRT)

Recruiting
  • Sarcoma
  • Radiosurgery
  • Caen, France
  • +10 more
Jul 22, 2022

SBRT Treatment for Lung Metastasis From Soft Tissue Sarcoma

Active, not recruiting
  • Metastasis From Malignant Tumor of Soft Tissues
  • Lung metastasis from soft-tissue sarcoma
  • Rozzano, MI, Milan, Italy
    Istituto Clinico Humanitas
May 3, 2022

Sarcoma, Metastatic Disease, Bony Sites Trial in United States (SBRT)

Completed
  • Sarcoma
  • +2 more
  • SBRT
  • Stanford, California
  • +4 more
Aug 13, 2020

Pancreatic Ductal Adenocarcinoma, Oligometastatic Disease Trial in Baltimore (FOLFIRINOX chemo)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Oligometastatic Disease
  • FOLFIRINOX chemotherapy
  • Baltimore, Maryland
    Johns Hopkins Hospital
Nov 2, 2023

Oligometastatic Hormone Sensitive Prostate Cancer Trial in Florence (SBRT on all sites of metastatic disease+Apalutamide)

Not yet recruiting
  • Oligometastatic Hormone Sensitive Prostate Cancer
  • SBRT on all sites of metastatic disease+Apalutamide
  • Florence, Italy
    AOU Careggi Radiation Oncology Unit
Jan 29, 2023

Oligometastatic Prostate Carcinoma Trial in China (ADT combined with abiraterone, neoadjuvant hormone and RT)

Not yet recruiting
  • Oligometastatic Prostate Carcinoma
  • ADT combined with abiraterone
  • neoadjuvant hormone and RT
  • Hefei, Anhui, China
  • +5 more
Jan 28, 2023

Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving

Recruiting
  • Non-small Cell Lung Cancer
  • Oligometastatic Disease
  • ctDNA testing and whole exome sequencing
  • Guangzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Dec 5, 2022

Unresectable Lung Non-Small Cell Carcinoma Trial (serplulimab plus chemo as conversion treatment)

Not yet recruiting
  • Unresectable Lung Non-Small Cell Carcinoma
  • serplulimab plus chemotherapy as conversion treatment
  • (no location specified)
Apr 27, 2023

Spinal Metastases, Spinal Tumor, Radiotherapy Trial in Shanghai (total en bloc spondylectomy)

Recruiting
  • Spinal Metastases
  • +4 more
  • total en bloc spondylectomy
  • Shanghai, Shanghai, China
    Shanghai Changzheng hospital
Nov 9, 2023

Colorectal Cancer, Oligometastatic Disease Trial in Australia (Local Ablative Therapy, Standard first-line systemic treatment)

Recruiting
  • Colorectal Cancer
  • Oligometastatic Disease
  • Local Ablative Therapy
  • Standard first-line systemic treatment
  • Albury, New South Wales, Australia
  • +8 more
May 15, 2023

Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)

Active, not recruiting
  • Sarcoma, Soft Tissue
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
Oct 29, 2023

Protocol For Bone and Soft Tissue Sarcomas

Completed
  • Sarcomas
    • Mumbai, Maharashtra, India
      Tata Memorial Hospital
    Apr 11, 2023

    Prostate Cancer Trial ([177Lu]Lu-PSMA I&T, Stereotactic Radiotherapy)

    Not yet recruiting
    • Prostate Cancer
    • [177Lu]Lu-PSMA I&T
    • Stereotactic Radiotherapy
    • (no location specified)
    May 30, 2023

    Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Cairo (radiation, procedure, other)

    Recruiting
    • Breast Cancer
    • +2 more
    • Stereotactic Ablative Radiation Therapy
    • +2 more
    • Cairo, Egypt
      National Cancer Institute
    Nov 20, 2023

    Ewing Sarcomas, Chondrosarcomas, Osteosarcomas Trial in France (Regorafenib, Placebo)

    Recruiting
    • Ewing Sarcomas
    • +4 more
    • Besancon, France
    • +18 more
    Apr 1, 2022

    Ovarian Cancer Recurrent Trial in Sutton, London (Niraparib oral capsule, SBRT)

    Not yet recruiting
    • Ovarian Cancer Recurrent
    • Niraparib oral capsule
    • SBRT
    • Sutton, Surrey, United Kingdom
    • +1 more
    Aug 10, 2023

    Effectiveness, Sexuality Trial in Zhengzhou (Lenvatinib mesylate capsule)

    Not yet recruiting
    • Effectiveness
    • Sexuality
    • Lenvatinib mesylate capsule
    • Zhengzhou, Henan, China
      Department of Bone and Soft Tissue ,Henan Cancer Hospital
    Jan 31, 2023

    Prostate Cancer Trial in Washington, Baltimore (drug, procedure, radiation)

    Completed
    • Prostate Cancer
    • Leuprolide Acetate
    • +4 more
    • Washington, District of Columbia
    • +2 more
    Jul 11, 2022

    Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

    Active, not recruiting
    • Metastatic Melanoma
    • +22 more
    • Ipilimumab
    • +3 more
    • Birmingham, Alabama
    • +24 more
    Jan 19, 2023

    Prostate Cancer Trial in Baltimore (Radium-223, stereotactic ablative radiotherapy (SABR))

    Recruiting
    • Prostate Cancer
    • Baltimore, Maryland
      Johns Hopkins
    May 25, 2022

    Colorectal Cancer Metastatic Trial in Philadelphia (Local consolidative therapy)

    Withdrawn
    • Colorectal Cancer Metastatic
    • Local consolidative therapy
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Dec 7, 2022

    Lung Cancer, Interstitial Lung Disease Trial in London, Montreal (N-Acetyl cysteine, Dexamethasone Oral, N-Acetyl cysteine

    Not yet recruiting
    • Lung Cancer
    • Interstitial Lung Disease
    • N-Acetyl cysteine
    • +3 more
    • London, Ontario, Canada
    • +1 more
    Aug 1, 2023

    Treatment Trial in Shanghai (ADT, SBRT)

    Recruiting
    • Treatment
    • Shanghai, Shanghai, China
      Changhai hospital
    Aug 9, 2022

    MPNST, NF1, Sarcoma Trial in United States (Selumetinib)

    Not yet recruiting
    • MPNST
    • +2 more
    • Birmingham, Alabama
    • +13 more
    Jun 29, 2022

    Metastasis, Metastatic Breast Cancer, Metastatic Prostate Cancer Trial in Spain (To propose a diagnostic test to determine the

    Recruiting
    • Metastasis
    • +4 more
    • To propose a diagnostic test to determine the viability of Stereotactic ABlative Radiotherapy (SABR).
    • +2 more
    • Reus, Tarragona, Spain
    • +20 more
    Jul 3, 2023